• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    DIH Appoints Anthony Pratt as Vice President of Commercial for the Americas

    4/15/24 4:05:00 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email

    NORWELL, Mass., April 15, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced the appointment of Mr. Anthony Pratt as Vice President of Commercial for the Americas. 

    Mr. Pratt brings a wealth of experience to DIH, having held key commercial positions at Ekso Bionics Inc., Echosens Inc., Intuitive Surgical Inc., Dentsply Inc., and Applied Systems Inc. His expertise in driving strategic initiatives and fostering market expansion aligns with the Company's growth initiatives in the region. As the newly appointed Vice President of Commercial, Mr. Pratt will play a critical role in overseeing business operations in the Americas, where he is expected to broaden the DIH footprint, strengthen market position, and foster thought-leadership with key industry partners.

    "We are thrilled to welcome Mr. Pratt to our team," said Dr. Patrick Bruno, Chief Market Officer of DIH. "Recognized for his comprehensive skill set and a proven track record of success, Anthony is a dynamic leader capable of driving organizational excellence and facilitating the Company's growth strategy. We look forward to the expertise and guidance he will provide to operations throughout the Americas."

    Prior to joining DIH, Mr. Pratt served as Vice President of Sales for North America at Ekso Bionics Inc., a healthcare technology company, where he successfully managed multiple business units, drove significant revenue inflection, and actively contributed to the company's strategic direction. Additionally, Mr. Pratt assumed selected investor relations responsibilities at Ekso Bionics' and served on its Board of Directors.

    About DIH Holding US, Inc.

    DIH stands for the vision to "Deliver Inspiration & Health" to improve the functioning of millions of people with disability and functional impairments. DIH is a global solution provider in blending innovative robotic and virtual reality ("VR") technologies with clinical integration and insights. Built through the mergers of global-leading niche technologies providers, DIH is positioning itself as a transformative total smart solutions provider and consolidator in a largely fragmented and manual-labor-driven industry.

    DIH website: www.DIH.com

    Investor Contact:

    Greg Chodaczek

    Gilmartin Group

    [email protected]



    Primary Logo

    Get the next $DHAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DIH Announces Fiscal 2025 Fourth Quarter and Fiscal Year End Financial Results

    NORWELL, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the fiscal 2025 fourth quarter and fiscal year ended March 31, 2025. Recent Highlights Revenue of $62.9 million for the fiscal year ended March 31, 2025, representing a decrease of 2.5% over the prior year Device revenue of $49.7

    10/20/25 5:05:09 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holding US, Inc. Announces Reverse Stock Split of its Series A Common Stock

    NORWELL, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) today announced that it will implement a reverse stock split of its Class A Common Stock, par value $0.0001 per share (the "Common Stock"), at a ratio of 1-for-25 (the "Reverse Stock Split"). The Reverse Stock Split was approved by the Company's stockholders at the Company's Special Meeting of Stockholders held on September 25, 2025, with the final ratio subsequently determined by the Company's Board of Directors on September 26, 2025. The Reverse Stock Split will take effect at market open on October 20, 2025, and the Common Stock will trade on a post-split basis on the Nasdaq Sto

    10/16/25 8:00:00 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holding US, Inc. Clarifies Previous Disclosure Regarding Additional Nasdaq Staff Determination Letter

    NORWELL, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- On September 18, 2025, DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) issued a press release disclosing that it had received a notice on September 12, 2025, from the Listing Qualifications Staff ("Staff") of the Nasdaq Stock Market LLC ("Nasdaq") that it had failed to regain compliance under Nasdaq Listing Rule 5450(b)(2)(A) (the "Bid Price Rule"), so this matter was an additional basis for delisting. The Company is clarifying that since it was not current in filing its Form 10-Q for the period ended June 30, 2025, and Form 10-K for the fiscal year ended March 31, 2025 under Nasdaq Listing Rule 5250(c)(1) (the "Reports Rule"),

    10/1/25 8:11:40 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    SEC Filings

    View All

    DIH Holdings US Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    11/26/25 9:32:54 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holdings US Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Unregistered Sales of Equity Securities

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    11/6/25 6:03:40 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holdings US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    10/21/25 4:45:55 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Mooney Barrett claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    9/8/25 5:15:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Burell Scott R claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    8/11/25 4:05:17 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Streppa Dennis claimed ownership of 78,022 shares (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    7/25/25 4:30:13 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    View All

    DIH Announces Fiscal 2025 Fourth Quarter and Fiscal Year End Financial Results

    NORWELL, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the fiscal 2025 fourth quarter and fiscal year ended March 31, 2025. Recent Highlights Revenue of $62.9 million for the fiscal year ended March 31, 2025, representing a decrease of 2.5% over the prior year Device revenue of $49.7

    10/20/25 5:05:09 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Barrett Mooney, Ph.D. to its Board of Directors. Barrett Mooney, Ph.D., has an extensive track record of growing complex and manufacturing related businesses. He currently provides strategic advisory services to growing high-technology private and public compan

    9/8/25 4:46:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 6:07:49 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 12:46:18 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by DIH Holdings US Inc.

    SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

    2/20/24 5:18:47 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care